Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Alzheimer disease: BACE1 branches out

Nature Medicine volume 12, page 1123 (2006)Cite this article

Access through your institution
Buy or subscribe

The enzyme, BACE1 (beta-site amyloid precursor protein–cleaving enzyme 1), is required to cleave amyloid-β from a larger precursor. (After BACE1-mediated cleavage, the presenilin-containing complex γ-secretase makes the final cleavage, liberating amyloid-β.)

Michael Willem et al. found that BACE1 seems to be required for processing a signal, the EGF-like factor neuregulin 1,that activates receptors on Schwann cells. Activation of these receptors is required for myelination.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Access through your institution
Authors
  1. Charlotte Schubert
    View author publications

    Search author on:PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Schubert, C. Alzheimer disease: BACE1 branches out. Nat Med 12, 1123 (2006). https://doi.org/10.1038/nm1006-1123

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nm1006-1123

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing